A Secondary Analysis of a Duration Response Association Between Selective Serotonin Reuptake Inhibitor Use and the Risk of Acute Myocardial Infarction in the Aging Population

Annals of Epidemiology

Volumn 18, Issue 4, 2008, Pages 316-321

  Blanchette, Christopher M ^a   Simoni Wastila, Linda ^b   Zuckerman, Ilene H ^b   Stuart, Bruce ^b  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Acute Myocardial Infarction; Antidepressants; Selective Serotonin Reuptake Inhibitor; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ACUTE HEART INFARCTION; AGED; ANXIETY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEPRESSION; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; GENDER; GERIATRIC PATIENT; HEALTH MAINTENANCE ORGANIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICARE CURRENT BENEFICIARY SURVEY; PRESCRIPTION; PRIORITY JOURNAL; RACE; STATISTICAL SIGNIFICANCE; STRATIFICATION; TREATMENT DURATION; TREATMENT RESPONSE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; UNITED STATES;

EID: 40949127013     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2007.11.004     Document Type: Article

References (34)

1. Judd L.L. Surveys show that 20-30% of elderly patients exhibit SSD symptomatology. Int Med World Rep 12 (1997) 33-34
2. Unutzer J., Patrick D., Simon G., et al. Depressive symptoms and the cost of health services in HMO patients aged 65 and older. JAMA 277 (1997) 1618-1623
3. Arnold A.M., Psaty B.M., Kuller L.H., et al. Incidence of cardiovascular disease in older Americans: The cardiovascular health study. J Am Geriatr Soc 53 2 (2005) 211-218
4. Penninx B.W., Beekman A.T., Honig A., et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 58 (2001) 221-227
5. Ford D.E., Mead L.A., Chang P.P., et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 158 (1998) 1422-1426
6. Barefoot J.C., and Schroll M. Symptoms of depression, acute myocardial infarction and total mortality in a community sample. Circulation 93 (1996) 1976-1980
7. Pratt L.A., Ford D.E., Crum R.M., et al. Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 94 (1996) 3123-3129
8. Frasure-Smith N., Lespérance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
9. Stewart R.A., North F.M., West T.M., et al. Depression and cardiovascular morbidity and mortality: cause or consequence?. Eur Heart J 24 (2003) 2027-2037
10. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55 (1998) 580-592
11. Musselman D.L., Marzec U.M., Manatunga A., et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 57 (2000) 875-882
12. Markovitz J.H., and Matthews K.A. Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 53 (1991) 643-668
13. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 153 (1996) 1313-1317
14. Lederbogen F., Gilles M., Maras A., et al. Increased platelet aggregability in major depression?. Psychiatry Res 102 (2001) 255-261
15. Zellweger M.J., Osterwalder R.H., Langewitz W., and Pfisterer M.E. Coronary artery disease and depression. Eur Heart J 25 (2004) 3-9
16. Willerson J.T. Serotonin and thrombotic complications. J Cardiovasc Pharmacol 17 Suppl 5 (1991) S13-S20
17. Vikenes K., Farstad M., and Nordrehaug J.E. Serotonin is associated with coronary artery disease and cardiac events. Circulation 100 (1999) 483-489
18. Schini-Kerth V.B., Fisslthaler B., Van Obberghen-Schilling E., and Busse R. Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells. Role of protein kinase C and protein tyrosine kinases. Circulation 93 (1996) 2170-2177
19. Glassman A.H., Roose S.P., and Bigger J.T. The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 269 (1993) 2673-2675
20. Schlienger R.G., Fischer L.M., Jick H., and Meier C.R. Current use of selective serotonin reuptake inhibitors and risk of acute myocardial infarction. Drug Safety 27 (2004) 1157-1165
21. Celada P., Dolera M., Alvarez E., and Artigas F. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Disord 25 (1992) 243-249
22. Hergovich N., Aigner M., Eichler H.G., et al. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther 68 (2000) 435-442
23. Serebruany V.L., O'Connor C.M., and Gurbel P.A. Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease. Am J Cardiol 87 (2001) 1398-1400
24. Maurer-Spurej E., Pittendreigh C., and Solomons K. The influence of selective serotonin reuptake inhibitors on human platelet serotonin. Thromb Haemost 91 (2004) 119-128
25. Schlienger R.G., and Meier C.R. Effect of selective serotonin reuptake inhibitors on platelet activation : can they prevent acute myocardial infarction?. Am J Cardiovasc Drugs 3 (2003) 149-162
26. Irvine J., Basinski A., Baker B., et al. Depression and risk of sudden cardiac death after acute myocardial infarction: testing for the confounding effects of fatigue. Psychosom Med 61 (1999) 729-737
27. Cohen H.W., Gibson G., and Alderman M.H. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med 108 (2000) 2-8
28. Sauer W.H., Berlin J.A., and Kimmel S.E. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 104 (2001) 1894-1898
29. Sauer W.H., Berlin J.A., and Kimmel S.E. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108 (2003) 32-36
30. Meier C.R., Schlienger R.G., and Jick H. Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol 52 (2001) 179-184
31. Tata L.J., West J., Smith C., et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91 (2005) 465-471
32. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
33. Fisher E.S., Wennberg D.E., Stukel T.A., et al. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Ann Intern Med 138 (2003) 288-298
34. Pope G.C., Kautter J., Ellis R.P., et al. Risk adjustment of Medicare capitation payments using the CMS-HCC model. Health Care Finance Rev 25 4 (2004) 119-141